Profil
Yu Hong Geng is Executive President-Macromolecule Business Unit at Yifan Pharmaceutical Co., Ltd. since 2025.
Former positions include Member-Supervisory Board at BIOTON SA and Vice President at Shanghai United Cell Biotechnology Co. Ltd. from 2014 to 2021.
Education includes a doctorate from The University of Hong Kong in 2002 and a graduate degree from Fudan University in 1996.
Aktive Positionen von Yu Hong Geng
| Unternehmen | Position | Beginn |
|---|---|---|
| YIFAN PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | 05.09.2025 |
Ehemalige bekannte Positionen von Yu Hong Geng
| Unternehmen | Position | Ende |
|---|---|---|
Shanghai United Cell Biotechnology Co. Ltd.
Shanghai United Cell Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals and vaccines | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2014 |
| BIOTON S.A. | Direktor/Vorstandsmitglied | - |
Ausbildung von Yu Hong Geng
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of Hong Kong
University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yifan Pharmaceutical Co., Ltd.
Yifan Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines, pharmaceuticals and biochemical products | Health Technology |
BIOTON SA
BIOTON SA Pharmaceuticals: MajorHealth Technology Manufactures medicines and pharmaceutical preparations and substances | Health Technology |
Fudan University
Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai United Cell Biotechnology Co. Ltd.
Shanghai United Cell Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals and vaccines | Health Technology |
















